Javascript must be enabled to continue!
Potential Serological Misdiagnosis of Barmah Forest Virus and Ross River Virus Diseases as Chikungunya Virus Infections in Australia: Comparison of ELISA with Neutralization Assay Results
View through CrossRef
To evaluate the frequency of errors in the diagnosis of medical laboratory-diagnosed Chikungunya virus (CHIKV) infections in Australia, we studied 42 laboratory-diagnosed CHIKV serum samples from one Queensland medical laboratory by ELISA IgG/IgM and measured the specific neutralization antibodies (Nab) against Barmah Forest virus (BFV), CHIKV and Ross River virus (RRV). The sero-positivity rates for the sera were as follows: anti-BFV IgG+ 19% (8/42), IgM+ 2.4% (1/42) and Nab+ 16.7% (7/42); anti-CHIKV IgG+ 90.5% (38/42), IgM+ 21.4% (9/42) and Nab+ 90.5% (38/42); anti-RRV IgG+ 88.1% (37/42), IgM+ 28.6% (12/42) and Nab+ 83.2% (35/42), respectively. Among the samples with multiple antibody positivity, 2.4% (1/42) showed triple ELISA IgM+, and 14.3% (6/42) exhibited double IgM RRV+CHIKV+; 9.5% (4/42) showed triple IgG+, 76.2% (32/42) displayed double IgG RRV+CHIKV+, 4.8% (2/42) showed IgG BFV+RRV+ and 4.8% (2/42) showed IgG BFV++CHIKV+; and 9.5% (4/42) showed triple Nab+ and 69% (29/42) exhibited double Nab RRV+CHIKV+, respectively. Our analysis of the single-virus infection control Nab results suggested no cross-neutralization between RRV and BFV, and only mild cross-neutralization between CHIKV and RRV, BFV and CHIKV, all with a ≥4-fold Nab titre ratio difference between the true virus infection and cross-reactivity counterpart virus. Subsequently, we re-diagnosed these 42 patients as 1 BFV+, 8 CHIKV+ and 23 RRV+ single-virus infections, along with five RRV+/BFV+ and four RRV+/CHIKV+ double infections, and one possible RRV+/BFV+ or RRV+CHIKV+, respectively. These findings suggests that a substantial proportion of medically attended RRV and BFV infections were misdiagnosed as CHIKV infections, highlighting the imperative need for diagnostic laboratory tests capable of distinguishing between CHIKV infections and actively co-circulating RRV and BFV. For a correct diagnosis, it is crucial to consider reliable diagnostic methods such as the neutralization assay to exclude RRV and BFV.
Title: Potential Serological Misdiagnosis of Barmah Forest Virus and Ross River Virus Diseases as Chikungunya Virus Infections in Australia: Comparison of ELISA with Neutralization Assay Results
Description:
To evaluate the frequency of errors in the diagnosis of medical laboratory-diagnosed Chikungunya virus (CHIKV) infections in Australia, we studied 42 laboratory-diagnosed CHIKV serum samples from one Queensland medical laboratory by ELISA IgG/IgM and measured the specific neutralization antibodies (Nab) against Barmah Forest virus (BFV), CHIKV and Ross River virus (RRV).
The sero-positivity rates for the sera were as follows: anti-BFV IgG+ 19% (8/42), IgM+ 2.
4% (1/42) and Nab+ 16.
7% (7/42); anti-CHIKV IgG+ 90.
5% (38/42), IgM+ 21.
4% (9/42) and Nab+ 90.
5% (38/42); anti-RRV IgG+ 88.
1% (37/42), IgM+ 28.
6% (12/42) and Nab+ 83.
2% (35/42), respectively.
Among the samples with multiple antibody positivity, 2.
4% (1/42) showed triple ELISA IgM+, and 14.
3% (6/42) exhibited double IgM RRV+CHIKV+; 9.
5% (4/42) showed triple IgG+, 76.
2% (32/42) displayed double IgG RRV+CHIKV+, 4.
8% (2/42) showed IgG BFV+RRV+ and 4.
8% (2/42) showed IgG BFV++CHIKV+; and 9.
5% (4/42) showed triple Nab+ and 69% (29/42) exhibited double Nab RRV+CHIKV+, respectively.
Our analysis of the single-virus infection control Nab results suggested no cross-neutralization between RRV and BFV, and only mild cross-neutralization between CHIKV and RRV, BFV and CHIKV, all with a ≥4-fold Nab titre ratio difference between the true virus infection and cross-reactivity counterpart virus.
Subsequently, we re-diagnosed these 42 patients as 1 BFV+, 8 CHIKV+ and 23 RRV+ single-virus infections, along with five RRV+/BFV+ and four RRV+/CHIKV+ double infections, and one possible RRV+/BFV+ or RRV+CHIKV+, respectively.
These findings suggests that a substantial proportion of medically attended RRV and BFV infections were misdiagnosed as CHIKV infections, highlighting the imperative need for diagnostic laboratory tests capable of distinguishing between CHIKV infections and actively co-circulating RRV and BFV.
For a correct diagnosis, it is crucial to consider reliable diagnostic methods such as the neutralization assay to exclude RRV and BFV.
Related Results
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
GEOINFORMATION FOR DISASTER MANAGEMENT 2020 (GI4DM2020): PREFACE
GEOINFORMATION FOR DISASTER MANAGEMENT 2020 (GI4DM2020): PREFACE
Abstract. Across the world, nature-triggered disasters fuelled by climate change are worsening. Some two billion people have been affected by the consequences of natural hazards ov...
Febre Chikungunya
Febre Chikungunya
Introdução: O nome Chikungunya deriva de uma palavra em Makonde, uma língua falada por um grupo que vive no sudeste da Tanzânia e norte de Moçambique, que significa "aqueles que se...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
A human
ex vivo
dengue virus neutralization assay identifies priority antibodies and epitopes for vaccines and therapeutics
A human
ex vivo
dengue virus neutralization assay identifies priority antibodies and epitopes for vaccines and therapeutics
Abstract
Background
Dengue is the most prevalent arboviral disease, for which neither effective vaccines nor antivirals are ava...
Molecular identification and phylogenetic analysis of chikungunya virus among dengue-negative patients in Kolkata, India
Molecular identification and phylogenetic analysis of chikungunya virus among dengue-negative patients in Kolkata, India
Dengue and chikungunya are co-circulating vector-borne diseases that share a significant number of clinical symptoms. To identify variables to aid physicians in making rapid and ef...
A35 The first laboratory confirmation of chikungunya outbreak in Ethiopia
A35 The first laboratory confirmation of chikungunya outbreak in Ethiopia
Abstract
Chikungunya is a viral disease (genus Alphavirus) which is transmitted to humans by infected mosquitoes—including Aedes aegypti and A. albopictus. An outbre...
Diagnosis of Chikungunya infection: a Narrative Review
Diagnosis of Chikungunya infection: a Narrative Review
Chikungunya virus (CHIKV) is an arbovirus infects humans that lead to Chikungunya fever, usually characterized by intense joint pain and arthritis. The first case was identified in...

